Ligand Pharmaceuticals Inc SEC filings LGNYZ
Ligand Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to May 14, 2015. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 144 | Notice of proposed sale | Nov 4, 2026 | — |
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 3, 2026 | — |
| 4 | Insider transaction | Nov 3, 2026 | Oct 30, 2026 |
| 144 | Notice of proposed sale | Nov 2, 2026 | — |
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 30, 2026 |
| 144 | Notice of proposed sale | Oct 30, 2026 | — |
| 144 | Notice of proposed sale | Oct 30, 2026 | — |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Oct 2, 2026 |
| 4 | Insider transaction | Sep 24, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 24, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 22, 2026 | Sep 22, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 144 | Notice of proposed sale | Sep 10, 2026 | — |
| 4 | Insider transaction | Sep 8, 2026 | Sep 3, 2026 |
| 144 | Notice of proposed sale | Sep 3, 2026 | — |
| 8-K/A | Amended current report | Sep 2, 2026 | Jul 14, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 13, 2026 | — |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Aug 3, 2026 |
| S-8 | Employee stock plan registration | Jul 22, 2026 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Regulation FD disclosure
|
Jul 14, 2026 | Jul 14, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jun 30, 2026 |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Jun 25, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 22, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 144 | Notice of proposed sale | Jun 16, 2026 | — |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 144 | Notice of proposed sale | Jun 12, 2026 | — |
| 144 | Notice of proposed sale | Jun 11, 2026 | — |
| 144 | Notice of proposed sale | Jun 10, 2026 | — |
| 144 | Notice of proposed sale | Jun 10, 2026 | — |
| 144 | Notice of proposed sale | Jun 10, 2026 | — |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | May 28, 2026 | May 27, 2026 |
| DEFA14A | Additional proxy material | May 18, 2026 | — |
| 8-K |
Current report
Material agreement
|
May 18, 2026 | May 16, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 1, 2026 |
| 144 | Notice of proposed sale | May 13, 2026 | — |
| 144 | Notice of proposed sale | May 12, 2026 | — |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 1, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | May 1, 2026 | — |
| 144 | Notice of proposed sale | May 1, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 1, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 1, 2026 | — |
| 8-K |
Current report
Agreement ended
|
Apr 30, 2026 | Apr 24, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Apr 27, 2026 | Apr 27, 2026 |
| ARS | Annual report to shareholders | Apr 21, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 144 | Notice of proposed sale | Apr 1, 2026 | — |
| 4 | Insider transaction | Mar 31, 2026 | Mar 6, 2026 |
| 4 | Insider transaction | Mar 27, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 27, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 27, 2026 | Mar 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 4 | Insider transaction | Mar 25, 2026 | Mar 23, 2026 |
| 144 | Notice of proposed sale | Mar 23, 2026 | — |
| 4 | Insider transaction | Mar 13, 2026 | Mar 11, 2026 |
| 144 | Notice of proposed sale | Mar 11, 2026 | — |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 144 | Notice of proposed sale | Mar 6, 2026 | — |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| S-3ASR | Automatic shelf registration | Feb 27, 2026 | — |
| 10-K | Annual report | Feb 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 14, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 14, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 14, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Dec 31, 2025 |
| 144 | Notice of proposed sale | Jan 2, 2026 | — |
| 4 | Insider transaction | Dec 19, 2025 | Dec 17, 2025 |
| 4 | Insider transaction | Dec 18, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 18, 2025 | Dec 18, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 144 | Notice of proposed sale | Dec 12, 2025 | — |
| 4 | Insider transaction | Dec 9, 2025 | Dec 5, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 144 | Notice of proposed sale | Dec 1, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 10, 2025 | Nov 6, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 10, 2025 | — |
| 144 | Notice of proposed sale | Nov 7, 2025 | — |
| 144 | Notice of proposed sale | Nov 7, 2025 | — |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Nov 5, 2025 | Nov 3, 2025 |
| 144 | Notice of proposed sale | Nov 3, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 17, 2025 | — |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 144 | Notice of proposed sale | Oct 1, 2025 | — |
| 4 | Insider transaction | Sep 24, 2025 | Sep 23, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 144 | Notice of proposed sale | Sep 23, 2025 | — |
| 144 | Notice of proposed sale | Sep 17, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
Sep 16, 2025 | Sep 12, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 2, 2025 |
| 144 | Notice of proposed sale | Sep 2, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Aug 14, 2025 | Aug 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 4 | Insider transaction | Aug 12, 2025 | Aug 10, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 11, 2025 | Aug 11, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 144 | Notice of proposed sale | Aug 1, 2025 | — |
| 4 | Insider transaction | Jul 11, 2025 | Jul 10, 2025 |
| 144 | Notice of proposed sale | Jul 10, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Jul 3, 2025 | — |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| 3 | Initial insider ownership | Jul 3, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 3/A | Primary document | Jul 2, 2025 | Nov 1, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 2, 2025 | Jul 2, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 23, 2025 |
| 144 | Notice of proposed sale | Jun 23, 2025 | — |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 144 | Notice of proposed sale | Jun 10, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | Aug 10, 2024 |
| 4 | Insider transaction | Jun 2, 2025 | Jan 17, 2025 |
| 144 | Notice of proposed sale | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 17, 2025 | Apr 16, 2025 |
| 4 | Insider transaction | Apr 16, 2025 | Apr 1, 2025 |
| 144 | Notice of proposed sale | Mar 18, 2025 | — |
| 4 | Insider transaction | Mar 6, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 6, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 6, 2025 | Mar 4, 2025 |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 25, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| 4 | Insider transaction | Dec 26, 2024 | Dec 23, 2024 |
| 144 | Notice of proposed sale | Dec 23, 2024 | — |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 2, 2024 | Nov 27, 2024 |
| 144 | Notice of proposed sale | Nov 27, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 144 | Notice of proposed sale | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LGND (Nasdaq), LGNDZ (OTC), LGNXZ (OTC), LGNYZ (OTC), LGNZZ (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 886163
- Former names
- LIGAND PHARMACEUTICALS (until Sep 13, 1994)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.